$60,000 of GENMAB lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022. General Medicare/Medicaid Issues. Safe STEP Act. 340B Issues."
You can find more data on corporate lobbying on Quiver Quantitative.
GMAB Congressional Stock Trading
Members of Congress have traded $GMAB stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GMAB stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 12/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GMAB Hedge Fund Activity
We have seen 122 institutional investors add shares of GMAB stock to their portfolio, and 91 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ORBIS ALLAN GRAY LTD added 1,676,793 shares (+inf%) to their portfolio in Q3 2024, for an estimated $40,880,213
- MORGAN STANLEY added 611,013 shares (+59.4%) to their portfolio in Q3 2024, for an estimated $14,896,496
- BLACKROCK, INC. removed 463,599 shares (-9.1%) from their portfolio in Q3 2024, for an estimated $11,302,543
- RENAISSANCE TECHNOLOGIES LLC added 323,969 shares (+22.2%) to their portfolio in Q3 2024, for an estimated $7,898,364
- HARDING LOEVNER LP added 299,137 shares (+10.8%) to their portfolio in Q3 2024, for an estimated $7,292,960
- TWO SIGMA ADVISERS, LP added 280,900 shares (+84.1%) to their portfolio in Q3 2024, for an estimated $6,848,342
- CUBIST SYSTEMATIC STRATEGIES, LLC removed 278,541 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $6,790,829
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
